文献速递关节外科

扩大医疗保险和医疗补助服务中心患者报告结局测量强制报告范围:评估全髋关节置换术结局超越髋关节功能障碍与骨关节炎结局评分-关节置换的实质临床获益

Expanding the Scope of Centers for Medicare and Medicaid Services Patient-Reported Outcome Measures Mandatory Reporting: Evaluating Total Hip Arthroplasty Outcomes Beyond Substantial Clinical Benefit for Hip Disability and Osteoarthritis Outcome Score-Joint Replacement.
PubMed 文献 · J Arthroplasty · 2025-09-26

该回顾性研究分析2016至2023年间18,855例初次全髋关节置换术病例,评估医疗保险或商业保险覆盖的住院和门诊患者达到HOOS-JR、HOOS-Pain和HOOS-PS的实质临床获益(SCB)、最小临床重要差异(MCID)和患者可接受症状状态(PASS)阈值的比例。结果显示达到临床意义阈值的比例因测量工具而异,SCB-JR与PASS-JR之间差异最大,引发对CMS政策仅依赖SCB-JR的担忧。

要点

  • 医疗保险住院患者达到HOOS-JR的SCB、MCID和PASS比例分别为80%、94%和59%。
  • 商业保险住院患者达到HOOS-JR的SCB、MCID和PASS比例分别为82%、95%和61%。
  • 达到临床意义阈值的比例因测量工具而异,SCB-JR与PASS-JR之间差异最大。

核心结论

  • 达到临床意义阈值的患者比例因所用测量工具而异,SCB-JR与PASS-JR之间差异最大。
  • 对新CMS政策下仅依赖SCB-JR提出担忧,因其可能未充分反映患者对改善的视角。

研究设计与样本

  • 回顾性研究,分析2016年至2023年间18,855例初次全髋关节置换术病例。
  • 记录人口统计学资料及HOOS-JR、HOOS-Pain和HOOS-PS评分。
  • HOOS-JR的SCB按CMS阈值设为22分。
  • 分析HOOS-JR、HOOS-Pain和HOOS-PS分别达到MCID(7.76、8.35、9.47)和PASS(76.8、80.6、83.6)阈值的情况。
  • 证据等级:II级。

主要发现

  • 医疗保险住院患者达到HOOS-JR临床意义阈值的比例:SCB为80%,MCID为94%,PASS为59%。
  • 医疗保险住院患者HOOS-Pain的MCID和PASS达到率分别为96%和69%,HOOS-PS分别为88%和67%。
  • 医疗保险门诊患者HOOS-JR的SCB、MCID和PASS达到率分别为85%、96%和71%,HOOS-Pain和HOOS-PS呈现相似模式。
  • 商业保险队列中,住院患者HOOS-JR的SCB、MCID和PASS达到率分别为82%、95%和61%,门诊患者分别为86%、97%和73%。

关键数值与推荐

  • HOOS-JR的SCB阈值为22分(依据CMS阈值)。
  • HOOS-JR、HOOS-Pain和HOOS-PS的MCID阈值分别为7.76、8.35、9.47。
  • HOOS-JR、HOOS-Pain和HOOS-PS的PASS阈值分别为76.8、80.6、83.6。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) has established the reporting of patient-reported outcome measures after inpatient total knee and total hip arthroplasty (THA) as a performance measure. However, its focus on substantial clinical benefit (SCB) for Hip Disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR) may not capture the full dimensions of patient-reported outcome measures. This study aimed to examine the proportions of the inpatient and outpatient THA patients, covered by Medicare or commercial insurance, who achieved different clinically meaningful improvements [SCB; minimal clinically important difference (MCID); and patient acceptable symptom state (PASS)] across HOOS-JR, HOOS-Pain, and HOOS-Physical Function Shortform (PS) scores. METHODS: A retrospective study of 18,855 primary THA cases between 2016 and 2023 was analyzed. Demographics and HOOS-JR, HOOS-Pain, and HOOS-PS scores were recorded. The SCB for HOOS-JR was set at 22 points per CMS threshold. Achievement of the thresholds for MCID (7.76, 8.35, 9.47) and PASS (76.8, 80.6, 83.6) for HOOS-JR, HOOS Pain, and HOOS-PS, respectively, was analyzed. RESULTS: The proportions of Medicare inpatients who achieved HOOS-JR clinically meaningful thresholds were 80% for SCB, 94% for MCID, and 59% for PASS. For HOOS-Pain, MCID, and PASS were achieved by 96 and 69%, respectively, and for HOOS-PS, by 88 and 67%. Medicare outpatients demonstrated higher rates of SCB (85%), MCID (96%), and PASS (71%) for HOOS-JR, with similar patterns for HOOS-Pain and PS. In the commercial cohort, inpatients achieved SCB, MCID, and PASS rates of 82, 95, and 61% for HOOS-JR, respectively, while outpatients reached 86, 97, and 73%. CONCLUSIONS: The proportions of patients who achieved clinically meaningful thresholds varied depending on the measurement used, with the greatest variation seen between SCB-JR and PASS-JR. This raises concerns about the sole reliance on SCB-JR under the new CMS policy, as it may not fully reflect the patient's perspective of improvement. LEVEL OF EVIDENCE: II.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Elmenawi KA, Pasqualini I, Khan ST, et al. Expanding the Scope of Centers for Medicare and Medicaid Services Patient-Reported Outcome Measures Mandatory Reporting: Evaluating Total Hip Arthroplasty Outcomes Beyond Substantial Clinical Benefit for Hip Disability and Osteoarthritis Outcome Score-Joint Replacement. J Arthroplasty. 2025. PMID: 41016609. doi:10.1016/j.arth.2025.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。